دورية أكاديمية
Molecular Biomarkers of Brain and Spinal Cord Astrocytomas.
| العنوان: | Molecular Biomarkers of Brain and Spinal Cord Astrocytomas. |
|---|---|
| المؤلفون: | Konovalov NA; National Medical Research Center of Neurosurgery, Ministry of Health of the Russian Federation Acad. N.N. Burdenko, 4th Tverskaya-Yamskaya Str. 16, Moscow, 125047, Russia., Asyutin DS; National Medical Research Center of Neurosurgery, Ministry of Health of the Russian Federation Acad. N.N. Burdenko, 4th Tverskaya-Yamskaya Str. 16, Moscow, 125047, Russia., Shayhaev EG; FGBU Russian Research Center for X-ray Radiology of the Ministry of Health of the Russian Federation Profsouznaya Str. 86, Moscow, 117485, Russia., Kaprovoy SV; National Medical Research Center of Neurosurgery, Ministry of Health of the Russian Federation Acad. N.N. Burdenko, 4th Tverskaya-Yamskaya Str. 16, Moscow, 125047, Russia., Timonin SY; National Medical Research Center of Neurosurgery, Ministry of Health of the Russian Federation Acad. N.N. Burdenko, 4th Tverskaya-Yamskaya Str. 16, Moscow, 125047, Russia. |
| المصدر: | Acta naturae [Acta Naturae] 2019 Apr-Jun; Vol. 11 (2), pp. 17-27. |
| نوع المنشور: | Journal Article |
| اللغة: | English |
| بيانات الدورية: | Publisher: National Research University Higher School of Economics Country of Publication: Russia (Federation) NLM ID: 101525823 Publication Model: Print Cited Medium: Print ISSN: 2075-8251 (Print) Linking ISSN: 20758251 NLM ISO Abbreviation: Acta Naturae Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2019- : [Moscow] : National Research University Higher School of Economics Original Publication: Moscow : Park Media Ltd |
| مستخلص: | Spinal cord astrocytomas are rare diseases of the central nervous system. The localization of these tumors and their infiltrative growth complicate their surgical resection, increase the risk of postoperative complications, and require more careful use of radio- and chemotherapy. The information on the genetic mutations associated with the onset and development of astrocytomas provides a more accurate neoplasm diagnosis and classification. In some cases, it also allows one to determine the optimal methods for treating the neoplasm, as well as to predict the treatment outcomes and the risks of relapse. To date, a number of molecular markers that are associated with brain astrocytomas and possess prognostic value have been identified and described. Due to the significantly lower incidence of spinal cord astrocytomas, the data on similar markers are much more sparse and are presented with a lesser degree of systematization. However, due to the retrospective studies of clinical material that have been actively conducted abroad in recent years, the formation of statistically significant genetic landscapes for various types of tumors, including intradural spinal cord tumors, has begun. In this regard, the purpose of this review is to analyze and systematize the information on the most significant genetic mutations associated with various types of astrocytomas, as well as discuss the prospects for using the corresponding molecular markers for diagnostic and prognostic purposes. |
| References: | Neuro Oncol. 2007 Jul;9(3):271-9. (PMID: 17504928) J Neuropathol Exp Neurol. 2012 Jul;71(7):631-9. (PMID: 22710963) J Clin Oncol. 2005 May 10;23(14):3227-34. (PMID: 15886310) Development. 2002 Jul;129(14):3513-22. (PMID: 12091320) Neuro Oncol. 2014 Jan;16(1):140-6. (PMID: 24285547) Neuro Oncol. 2018 May 18;20(6):729-742. (PMID: 29216380) Curr Opin Genet Dev. 2013 Jun;23(3):289-94. (PMID: 23453691) Spine (Phila Pa 1976). 2009 Oct 15;34(22 Suppl):S69-77. (PMID: 19829279) APMIS. 2014 Jan;122(1):81-2. (PMID: 23758177) Acta Neuropathol. 2013 Sep;126(3):443-51. (PMID: 23904111) Br J Cancer. 2009 Aug 18;101(4):722-33. (PMID: 19603027) Acta Neuropathol. 2016 Jan;131(1):147-50. (PMID: 26487540) Neuro Oncol. 2018 Nov 9;20(suppl_7):vii17-vii26. (PMID: 30412261) Brain Tumor Pathol. 2016 Oct;33(4):267-269. (PMID: 27236270) Genes Dev. 2010 Aug 15;24(16):1731-45. (PMID: 20713517) Clin Cancer Res. 2015 Jul 15;21(14):3307-17. (PMID: 25609060) Science. 2013 May 17;340(6134):857-61. (PMID: 23539183) Nat Rev Neurol. 2013 May;9(5):257-66. (PMID: 23528542) Science. 2001 Dec 7;294(5549):2186-9. (PMID: 11691952) Cancer Res. 2004 Oct 1;64(19):6892-9. (PMID: 15466178) Curr Neurol Neurosci Rep. 2011 Jun;11(3):320-8. (PMID: 21327734) Cancer Cell. 2010 May 18;17(5):510-22. (PMID: 20399149) Cancer Res. 1991 Apr 15;51(8):2164-72. (PMID: 2009534) Cancer Res. 2006 Apr 15;66(8):4531-41. (PMID: 16618782) Tumour Biol. 2013 Aug;34(4):2063-74. (PMID: 23737287) Brain Pathol. 2016 Jan;26(1):120-3. (PMID: 26443345) J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89. (PMID: 15977639) Nat Genet. 2013 Aug;45(8):927-32. (PMID: 23817572) Clin Med Oncol. 2009 Apr 8;3:39-52. (PMID: 19777070) World Neurosurg. 2017 Dec;108:991.e13-991.e16. (PMID: 28866063) Acta Neuropathol. 2015 Jun;129(6):829-48. (PMID: 25943888) Science. 2008 Sep 26;321(5897):1807-12. (PMID: 18772396) Mol Aspects Med. 2013 Jul-Aug;34(4):849-62. (PMID: 22771539) Neuro Oncol. 2012 Jun;14(6):777-89. (PMID: 22492957) Acta Neuropathol. 2007 Aug;114(2):97-109. (PMID: 17618441) Cancers (Basel). 2013 Aug 22;5(3):1103-19. (PMID: 24202336) Nat Commun. 2015 Jul 06;6:7538. (PMID: 26143912) Exp Neurol. 2019 Jan;311:135-147. (PMID: 30243796) Clin Cancer Res. 2012 Oct 15;18(20):5562-71. (PMID: 23071358) Toxicol Pathol. 2011 Jan;39(1):158-66. (PMID: 21078918) Acta Neuropathol. 2015 Sep;130(3):435-7. (PMID: 26231952) Neurosurgery. 2005 May;56(5):972-81; discussion 972-81. (PMID: 15854245) Eur Spine J. 2016 Dec;25(12):4067-4079. (PMID: 26984877) Nature. 2009 Dec 10;462(7274):739-44. (PMID: 19935646) Global Spine J. 2015 Oct;5(5):425-35. (PMID: 26430598) Clin Cancer Res. 2004 Jan 1;10(1 Pt 1):228-33. (PMID: 14734474) Nat Genet. 2012 Jan 29;44(3):251-3. (PMID: 22286216) Am J Pathol. 2009 Apr;174(4):1149-53. (PMID: 19246647) Am J Pathol. 2007 May;170(5):1445-53. (PMID: 17456751) Oncologist. 2017 Dec;22(12):1478-1490. (PMID: 28912153) Cancer Cell. 2012 Oct 16;22(4):425-37. (PMID: 23079654) Acta Neuropathol. 2015 Jun;129(6):775-88. (PMID: 25792358) J Natl Compr Canc Netw. 2014 May;12(5):665-72. (PMID: 24812135) Science. 2013 May 3;340(6132):626-30. (PMID: 23558169) Front Oncol. 2015 Mar 03;5:54. (PMID: 25785246) Mol Cancer. 2013 Apr 25;12:31. (PMID: 23617883) Acta Neuropathol. 2012 Sep;124(3):449-51. (PMID: 22772980) Int J Biochem Cell Biol. 2012 May;44(5):770-5. (PMID: 22309944) Acta Neuropathol. 2011 Mar;121(3):397-405. (PMID: 21274720) Brain Tumor Pathol. 2011 Oct;28(4):297-303. (PMID: 21643805) Nat Rev Mol Cell Biol. 2010 Apr;11(4):264-75. (PMID: 20197778) Expert Rev Neurother. 2016 Sep;16(9):1055-65. (PMID: 27228211) PLoS Med. 2006 Dec;3(12):e485. (PMID: 17177598) Neurosurg Focus. 2015 Mar;38(3):E4. (PMID: 25727226) J Korean Neurosurg Soc. 2010 Jan;47(1):68-70. (PMID: 20157383) Oncotarget. 2012 Oct;3(10):1194-203. (PMID: 23104868) Brain Pathol. 2012 Nov;22(6):841-7. (PMID: 22591444) J Natl Cancer Inst. 2001 Aug 15;93(16):1246-56. (PMID: 11504770) Br J Radiol. 2011 Dec;84 Spec No 2:S90-106. (PMID: 22433833) Cancer Res. 2003 Oct 15;63(20):6962-70. (PMID: 14583498) Acta Neuropathol. 2012 Sep;124(3):439-47. (PMID: 22661320) Tumour Biol. 2013 Aug;34(4):1991-2002. (PMID: 23625692) Brain Pathol. 2019 Jan;29(1):126-140. (PMID: 30192422) Neurol Clin. 2013 Feb;31(1):241-68. (PMID: 23186903) J Neurochem. 2019 Jan;148(2):188-203. (PMID: 30347482) J Pathol. 2010 Dec;222(4):324-8. (PMID: 20976706) Neuropathol Appl Neurobiol. 2015 Apr;41(3):403-8. (PMID: 25389051) Curr Opin Oncol. 1999 May;11(3):162-7. (PMID: 10328589) Proc Natl Acad Sci U S A. 2012 May 29;109(22):8710-5. (PMID: 22586120) Acta Neuropathol. 2010 May;119(5):641-9. (PMID: 20044755) Front Biosci. 2000 Jan 01;5:D213-31. (PMID: 10702383) Semin Oncol Nurs. 2018 Dec;34(5):430-442. (PMID: 30409555) Nature. 2012 Jan 29;482(7384):226-31. (PMID: 22286061) Clin Cancer Res. 2011 Jul 15;17(14):4790-8. (PMID: 21610142) Curr Neurol Neurosci Rep. 2017 Feb;17(2):19. (PMID: 28271343) Brain Pathol. 2016 Sep;26(5):569-80. (PMID: 26517431) Oncogene. 2009 May 21;28(20):2119-23. (PMID: 19363522) N Engl J Med. 2009 Feb 19;360(8):765-73. (PMID: 19228619) Oncotarget. 2012 Jul;3(7):709-22. (PMID: 22869205) J Neurosurg. 2003 Jan;98(1):106-16. (PMID: 12546358) Nature. 2012 Feb 15;483(7390):474-8. (PMID: 22343901) Cancer. 2012 Sep 1;118(17):4220-7. (PMID: 22907705) Clin Cancer Res. 2014 Nov 15;20(22):5601-11. (PMID: 25398843) Hum Pathol. 2015 Nov;46(11):1626-32. (PMID: 26297251) |
| فهرسة مساهمة: | Keywords: diagnosis; glioblastoma; mechanisms of neoplastic transformation; molecular markers; mutations; prognostic value; spinal cord astrocytoma |
| تواريخ الأحداث: | Date Created: 20190816 Latest Revision: 20240718 |
| رمز التحديث: | 20240718 |
| مُعرف محوري في PubMed: | PMC6643348 |
| DOI: | 10.32607/20758251-2019-11-2-17-27 |
| PMID: | 31413876 |
| قاعدة البيانات: | MEDLINE |
| تدمد: | 2075-8251 |
|---|---|
| DOI: | 10.32607/20758251-2019-11-2-17-27 |